Dr. Joel H. Rubenstein

Joel Rubenstein, M.D., M.Sc. is Director of the Barrett's Esophagus Program and Professor in the Division of Gastroenterology at the University of Michigan. He is also a Research Scientist at the Veterans Affairs Center of Excellence for Clinical Management Research.Dr. Rubenstein earned a Bachelors of Science from the University of Michigan, majoring in biophysics. He then earned his medical degree from Washington University in St. Louis. After completing his residency training in internal medicine at the University of Chicago, Dr. Rubenstein returned to the University of Michigan, where he completed fellowship training in gastroenterology, earned a Masters of Science in Clinical Research Design and Statistical Analysis, and then joined the faculty of the Division of Gastroenterology in 2004.Dr. Rubenstein is a recognized expert in the diagnosis and management of Barrett's esophagus, a precancerous lesion associated with esophageal cancer. His research aims to develop efficient management strategies for identifying Barrett's esophagus and preventing death from esophageal cancer. Dr. Rubenstein's research has been supported by the National Institutes of Health, the Department of Veterans Affairs, Department of Defense, the Damon Runyon Cancer Research Foundation, and other sources. In addition to Barrett's esophagus, Dr. Rubenstein has clinical expertise in other esophageal disoders, including achalasia and eosinophilic esophagitis.Dr. Rubenstein is the former Chair of the Clinical Practice Section of the American Gastroenterology Association, and current Associated Editor of the American Journal of Gastroenterology.

Dr. Rubenstein is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Barrett Esophagus, Gastroesophageal Reflux Disease (GERD), Esophageal Cancer, Endoscopy, and Colonoscopy.

Dr. Rubenstein is board certified in Gastroenterology. He is actively involved in clinical research, co-authoring 144 peer reviewed articles and participating in 2 clinical trials.